Reported that thymol could act as a safe and potent therapeutic agent to treat NSCLC by inducing mitochondrial pathway-mediated apoptosis via ROS generation, macromolecular damage and SOD diminution in A549 cells (24). Here, SOD1 is linked to non-small cell lung carcinoma.